Syntekabio, an artificial intelligence (AI) new drug development specialist company (CEO Jeong Jong-seon), announced on the 22nd that it has completed the registration of a patent for the "Method for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results